Li Chunxia, Dai Jun, Liu Chuanbin, Dong Guanjun, Zhang Xin, Zhang Junfeng, Yan Fenglian, Zhang Hui, Wang Changying, Zhao Mingsheng, Ning Zhaochen, Ma Qun, Shi Hui, Li Zhihua, Xiong Huabao
Institute of Immunology and Molecular Medicine, Basic Medical School, Jining Medical University, Jining, 272067, Shandong, China.
Department of Pediatric Dentistry, Jining Stomatological Hospital, Jining, 272067, Shandong, China.
Inflammation. 2023 Feb;46(1):418-431. doi: 10.1007/s10753-022-01744-8. Epub 2022 Sep 29.
Endotoxin shock remains one of the major causes of mortality worldwide. Pyruvate dehydrogenase kinase (PDK) 2 is an important regulatory enzyme involved in glucose metabolism. The purpose of this study was to determine the regulatory effect of PDK2 on LPS-induced endotoxin shock and explore the mechanisms in vivo and in vitro. Here, we showed that PDK2 contributed to Toll-like receptor (TLR)-mediated inflammation. Lipopolysaccharide (LPS) activation of TLR4 pathways resulted in PDK2 upregulation in macrophages and dendritic cells (DCs). PDK2 overexpression enhanced TLR4 signaling pathway activation, whereas downregulating PDK2 expression inhibited TLR4 signaling pathway activation. Pharmacological inhibition of PDK2 significantly decreased the mortality rate and alleviated pathological injury in the lungs and livers of LPS-challenged mice, while significantly suppressing proinflammatory cytokine production. Thus, we confirmed that PDK2 is involved in LPS-induced endotoxin shock by modulating TLR4-mitogen-activated protein kinase signaling and inducing the production of proinflammatory cytokines in macrophages and DCs. Our findings highlight the importance of PDK2 as a novel target to treat septic shock.
内毒素休克仍然是全球范围内主要的死亡原因之一。丙酮酸脱氢酶激酶(PDK)2是参与葡萄糖代谢的一种重要调节酶。本研究的目的是确定PDK2对脂多糖(LPS)诱导的内毒素休克的调节作用,并在体内和体外探索其机制。在此,我们发现PDK2促成了Toll样受体(TLR)介导的炎症反应。TLR4通路的脂多糖(LPS)激活导致巨噬细胞和树突状细胞(DCs)中PDK2上调。PDK2过表达增强了TLR4信号通路的激活,而下调PDK2表达则抑制了TLR4信号通路的激活。对PDK2的药理学抑制显著降低了LPS攻击小鼠的死亡率,减轻了肺和肝脏的病理损伤,同时显著抑制促炎细胞因子的产生。因此,我们证实PDK2通过调节TLR4-丝裂原活化蛋白激酶信号传导以及诱导巨噬细胞和DCs中促炎细胞因子的产生而参与LPS诱导的内毒素休克。我们的研究结果突出了PDK2作为治疗脓毒症休克新靶点的重要性。